AAMP and MTSS1 Are Novel Negative Regulators of Endothelial Barrier Function Identified in a Proteomics Screen
Cells · 2024
DOI: 10.3390/cells13191609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Fabienne Podieh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Microcirculation, Amsterdam Cardiovascular Science, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Proteomics, Ubiquitination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Weetenschappelijk Onderzoek (NWO), NWO, Cancer Center Amsterdam and Netherlands Organisation for Scientific Research.
Abstract (Originalsprache)
Cell–cell adhesion in endothelial monolayers is tightly controlled and crucial for vascular integrity. Recently, we reported on the importance of fast protein turnover for maintenance of endothelial barrier function. Specifically, continuous ubiquitination and degradation of the Rho GTPase RhoB is crucial to preserve quiescent endothelial integrity. Here, we sought to identify other barrier regulators, which are characterized by a short half-life, using a proteomics approach. Following short-term inhibition of ubiquitination with E1 ligase inhibitor MLN7243 or Cullin E3 ligase inhibitor MLN4924 in primary human endothelial cells, we identified sixty significantly differentially expressed proteins. Intriguingly, our data showed that AAMP and MTSS1 are novel negative regulators of endothelial barrier function and that their turnover is tightly controlled by ubiquitination. Mechanistically, AAMP regulates the stability and activity of RhoA and RhoB, and colocalizes with F-actin and cortactin at membrane ruffles, possibly regulating F-actin dynamics. Taken together, these findings demonstrate the critical role of protein turnover of specific proteins in the regulation of endothelial barrier function, contributing to our options to target dysregulation of vascular permeability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Microcirculation, Amsterdam Cardiovascular Science, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands.
- Department of Medical Oncology, OncoProteomics Laboratory, Cancer Center Amsterdam, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands.
ORCID-Profile: Peter L Hordijk
Förderung
- Nederlandse Organisatie voor Weetenschappelijk Onderzoek (NWO)
- NWO
- Cancer Center Amsterdam and Netherlands Organisation for Scientific Research
Zitieren
APA
Podieh, F., Overboom, M. C., Knol, J. C., Piersma, S. R., Goeij-de Haas, R., Pham, T. V., Jimenez, C. R., & Hordijk, P. L. (2024). AAMP and MTSS1 Are Novel Negative Regulators of Endothelial Barrier Function Identified in a Proteomics Screen. Cells. https://doi.org/10.3390/cells13191609
Vancouver
Podieh F, Overboom MC, Knol JC, Piersma SR, Goeij-de Haas R, Pham TV, et al. AAMP and MTSS1 Are Novel Negative Regulators of Endothelial Barrier Function Identified in a Proteomics Screen. Cells. 2024. doi:10.3390/cells13191609
BibTeX
@article{Podieh2024,
author = {Podieh, Fabienne and Overboom, Max C and Knol, Jaco C and Piersma, Sander R and Goeij-de Haas, Richard and Pham, Thang V and Jimenez, Connie R and Hordijk, Peter L},
title = {AAMP and MTSS1 Are Novel Negative Regulators of Endothelial Barrier Function Identified in a Proteomics Screen},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13191609}
}
EUVIMED